Wednesday, February 10, 2010, 11:54PM AEST - The Australian Stockmarket is closed.
To create a watchlist or portfolio of shares, Register

Meridian Bioscience Inc. (VIVO)

8:00AM AEST: 20.45 USD   0.00 (0.00%)  
 MORE ON VIVO 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Meridian Bioscience Inc. (NasdaqNM:VIVO) Delayed quote dataEdit
Last Trade:20.45 USD
Trade Time: 8:00AM AEST
Change: 0.00 (0.00%)
Prev Close:20.45
Open:N/A
Bid:0.01 x 100
Ask:2,000.00 x 100
1y Target Est:26.00
Day's Range:N/A - N/A
52wk Range:14.79 - 26.20
Volume:0
Avg Vol (3m):242,502
Market Cap:829.68M
P/E (ttm):25.66
EPS (ttm):0.80
Div & Yield:0.70 (3.42%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add VIVO to Portfolio   Download Data

 HEADLINES 
MERIDIAN BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue 2:04AM)
Great Call on Apple! What's Next?
at Motley Fool (Wed, Jan 27)
New Star Analyst Rankings for Meridian Bioscience Inc.
StarMine (Sun, Jan 24)
MERIDIAN BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
EDGAR Online (Sat, Jan 23)
Meridian Misses by a Penny
Zacks.com (Sat, Jan 23)
Meridian board boosts dividend by 12 percent
AP (Fri, Jan 22)
The Home Run Stock You're Too Afraid to Buy
at Motley Fool (Fri, Jan 22)
Flu season helps Meridian boost profits
at bizjournals.com (Fri, Jan 22)
Meridian 1Q profit jumps on flu test sales
AP (Fri, Jan 22)
Meridian Bioscience Reports Record First Quarter Sales and Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2010 Guidance
Business Wire (Thu, Jan 21)
Q1 2010 Meridian Bioscience, Inc Earnings Release - Before Market Open
CCBN (Thu, Jan 21)
More Headlines for VIVO...

 ANALYST 
EPS Est (next year) (Sep-10) :0.93
EPS Est (in 2 years) (Sep-11) :1.09
Avg Rec (current)*:2.4
PEG Ratio:1.40
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Meridian Bioscience, Inc. operates as an integrated life science company. The company primarily engages in the development, manufacture, sale, and distribution of diagnostic test kits primarily for respiratory, gastrointestinal, viral, and parasit...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices